Successful Treatment of Angioimmunoblastic T-cell Lymphoma with Clarithromycin

Overview

Journal Blood Res

Publisher Springer Nature

Specialty Hematology

Date 2016 Jul 7

PMID 27382561

Citations 2

Authors

Masashi Ohe

Satoshi Hashino

Affiliations

Soon will be listed here.

Citing Articles

Application of NanoString technologies in angioimmunoblastic T cell lymphoma.

Shin W, Mun S, Choi S, Han K Genes Genomics. 2020; 42(4):485-494.

PMID: 32146712 DOI: 10.1007/s13258-020-00919-7.

A case of Waldenström's macroglobulinemia treated using clarithromycin and prednisolone.

Ohe M, Hashino S, Shida H, Horita T, Sugiura M Transl Clin Pharmacol. 2020; 25(3):134-137.

PMID: 32095463 PMC: 7033378. DOI: 10.12793/tcp.2017.25.3.134.

References

de Leval L, Gisselbrecht C, Gaulard P . Advances in the understanding and management of angioimmunoblastic T-cell lymphoma. Br J Haematol. 2009; 148(5):673-89. DOI: 10.1111/j.1365-2141.2009.08003.x. View

Ohe M, Hashino S . Successful treatment with erythromycin for idiopathic thrombocytopenic purpura. Korean J Hematol. 2011; 46(2):139-42. PMC: 3128896. DOI: 10.5045/kjh.2011.46.2.139. View

Ohe M, Hashino S . A case of follicular B-cell lymphoma treated using clarithromycin. Korean J Hematol. 2011; 46(3):203-6. PMC: 3208206. DOI: 10.5045/kjh.2011.46.3.203. View

Zhao W, Mourah S, Mounier N, Leboeuf C, Daneshpouy M, Legres L . Vascular endothelial growth factor-A is expressed both on lymphoma cells and endothelial cells in angioimmunoblastic T-cell lymphoma and related to lymphoma progression. Lab Invest. 2004; 84(11):1512-9. DOI: 10.1038/labinvest.3700145. View

Dogan A, Ngu L, Ng S, Cervi P . Pathology and clinical features of angioimmunoblastic T-cell lymphoma after successful treatment with thalidomide. Leukemia. 2005; 19(5):873-5. DOI: 10.1038/sj.leu.2403710. View

Ratzinger F, Haslacher H, Poeppl W, Hoermann G, Kovarik J, Jutz S . Azithromycin suppresses CD4(+) T-cell activation by direct modulation of mTOR activity. Sci Rep. 2014; 4:7438. PMC: 4262884. DOI: 10.1038/srep07438. View

Hoeben A, Landuyt B, Highley M, Wildiers H, van Oosterom A, De Bruijn E . Vascular endothelial growth factor and angiogenesis. Pharmacol Rev. 2004; 56(4):549-80. DOI: 10.1124/pr.56.4.3. View

Aguiar Bujanda D . Complete response of relapsed angioimmunoblastic T-cell lymphoma following therapy with bevacizumab. Ann Oncol. 2008; 19(2):396-7. DOI: 10.1093/annonc/mdm579. View

Matsune S, Sun D, Ohori J, Nishimoto K, Fukuiwa T, Ushikai M . Inhibition of vascular endothelial growth factor by macrolides in cultured fibroblasts from nasal polyps. Laryngoscope. 2005; 115(11):1953-6. DOI: 10.1097/01.mlg.0000177031.06112.50. View

10.

Ishimatsu Y, Mukae H, Matsumoto K, Harada T, Hara A, Hara S . Two cases with pulmonary mucosa-associated lymphoid tissue lymphoma successfully treated with clarithromycin. Chest. 2010; 138(3):730-3. DOI: 10.1378/chest.09-2358. View

11.

Ohe M, Hashino S . [Successful treatment with clarithromycin for Mixed phenotype acute leukemia, T/myeloid, NOS]. Rinsho Ketsueki. 2010; 51(4):297-9. View

12.

Matsumura Y, Kuroda J, Shimura Y, Kiyota M, Yamamoto-Sugitani M, Kobayashi T . Cyclosporine A and reduced-intensity conditioning allogeneic stem cell transplantation for relapsed angioimmunoblastic T cell lymphoma with hemophagocytic syndrome. Intern Med. 2012; 51(19):2785-7. DOI: 10.2169/internalmedicine.51.8260. View

13.

Ohe M, Hashino S, Hattori A . Successful treatment of diffuse large B-cell lymphoma with clarithromycin and prednisolone. Korean J Hematol. 2013; 47(4):293-7. PMC: 3538802. DOI: 10.5045/kjh.2012.47.4.293. View

14.

Wu L, Zhang W, Tian L, Bao K, Li P, Lin J . Immunomodulatory effects of erythromycin and its derivatives on human T-lymphocyte in vitro. Immunopharmacol Immunotoxicol. 2007; 29(3-4):587-96. DOI: 10.1080/08923970701692841. View